Home > Category > Inhibitory Antibodies > Antibodies > Bevacizumab (anti-VEGF) | RhuMab VEGF

Bevacizumab (anti-VEGF) | RhuMab VEGF

ChemLeader 95+%

Catalog No：CLA1008 CAS No.：216974-75-3 MDLNo： Formula： MW：149 kDa

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$450.00	Visible after login	- +
5 mg	3-5days	$950.00	Visible after login	- +
10 mg	3-5days	$1800.00	Visible after login	- +
50 mg	3-5days	$6900.00	Visible after login	- +
100 mg	3-5days	$110000.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Bevacizumab (anti-VEGF) \| RhuMab VEGF
CAS	216974-75-3
MW	149 kDa
Storage condition	Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles

Product details

Bevacizumab (anti-VEGF, Avastin) is a humanized anti-VEGF monoclonal antibody which binds to and neutralizes all human VEGF-A isoforms and bioactive proteolytic fragments, MW:149 KD.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1008

Bevacizumab (anti-VEGF) | RhuMab VEGF

216974-75-3 95+%